Mind Medicine Inc [MNMD] stock prices are up 2.78% to $12.56 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MNMD shares have gain 17.71% over the last week, with a monthly amount glided 36.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Evercore ISI started tracking the stock with Outperform rating on January 28, 2025, and set its price target to $23. On December 20, 2024, Chardan Capital Markets initiated with a Buy rating and assigned a price target of $20 on the stock. ROTH MKM initiated its recommendation with a Buy and recommended $36 as its price target on July 24, 2024. Robert W. Baird started tracking with a Outperform rating for this stock on May 29, 2024, and assigned it a price target of $27. In a note dated April 15, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $20 on this stock.
The stock price of Mind Medicine Inc [MNMD] has been fluctuating between $4.70 and $12.70 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Mind Medicine Inc [NASDAQ: MNMD] shares were valued at $12.56 at the most recent close of the market. An investor can expect a potential return of 43.31% based on the average MNMD price forecast.
Analyzing the MNMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.5 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.13 points at the first support level, and at 11.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.88, and for the 2nd resistance point, it is at 13.19.
Ratios To Look Out For
It’s worth pointing out that Mind Medicine Inc [NASDAQ:MNMD]’s Current Ratio is 4.98. As well, the Quick Ratio is 4.98, while the Cash Ratio is 0.88.
Transactions by insiders
Recent insider trading involved Sullivan Mark, Chief Legal Officer, that happened on Sep 25 ’25 when 11278.0 shares were sold. Chief Executive Officer, Barrow Robert completed a deal on Sep 25 ’25 to sell 25797.0 shares. Meanwhile, Chief Medical Officer Karlin Daniel sold 7704.0 shares on Sep 25 ’25.
